Literature DB >> 18195685

Similar lymphocyte recovery and CMV reactivation profiles between reduced intensity conditioning with alemtuzumab and myeloablative allogeneic stem cell transplantation.

Q A Hill, A Hill, T A Collyns, R M Pearce, G Cook.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18195685     DOI： 10.1038/sj.bmt.1705974

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  2 in total

1.  Pharmacokinetics and clinical activity of very low-dose alemtuzumab in transplantation for acute leukemia.

Authors:  A Spyridonidis; M Liga; E Triantafyllou; M Themeli; M Marangos; M Karakantza; N Zoumbos
Journal:  Bone Marrow Transplant       Date:  2010-12-20       Impact factor: 5.483

2.  Impact of pretransplant donor and recipient cytomegalovirus serostatus on outcome for multiple myeloma patients undergoing reduced intensity conditioning allogeneic stem cell transplantation.

Authors:  Jean El-Cheikh; Raynier Devillier; Roberto Crocchiolo; Sabine Fürst; Boris Calmels; Catherine Faucher; Anne Marie Stoppa; Angela Granata; Luca Castagna; Patrick Ladaique; Claude Lemarie; Reda Bouabdallah; Christine Zandotti; Michele Merlin; Pierre Berger; Christian Chabannon; Didier Blaise
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-04-10       Impact factor: 2.576
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.